GO:2001235 positive regulation of apoptotic signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001235 describes any process that activates or increases the frequency, rate or extent of an apoptotic signaling pathway, placing it at the decision point between cell survival and cell death.
• Positive regulation of apoptotic signaling is executed by death receptor ligation, Bcl-2 family pore formation, caspase activation and mitochondrial outer membrane permeabilization.
• Key molecular players include TP53, BAX, BAK1, BID, caspase-8, caspase-9, caspase-3, cytochrome c, APAF1, FAS, TNFRSF10A/B and the PI3K/AKT/mTOR survival axis that opposes it.
• Dysregulated positive regulation of apoptotic signaling contributes to cancer, autoimmune disease, acute liver injury, renal tubular injury and myocardial apoptosis.
• Natural compounds such as shikonin, Saccharomyces cerevisiae fractions, anhydroicaritin and Fufang epimedium formula modulate this process through AMPK/mTOR/ULK-1, Akt/NF-kB, ESR1/MAPK and PI3K/AKT/Bcl-2 signaling.
• CRISPR knockout, point mutation, knock-in and overexpression models are the standard tools for causally testing genes that positively regulate apoptotic signaling.
Description
GO:2001235, positive regulation of apoptotic signaling pathway, is a Gene Ontology biological process term that captures every mechanism capable of activating or increasing the frequency, rate or extent of an apoptotic signaling pathway. Apoptotic signaling is the ordered biochemical cascade through which a cell commits to programmed death, and its positive regulation determines whether a death stimulus is amplified into irreversible execution or buffered by survival signaling. Because this term sits at the integration point of extrinsic death receptor cues and intrinsic mitochondrial cues, it is central to understanding how tissues eliminate damaged, infected or transformed cells. Mechanistically, positive regulation of apoptotic signaling is driven by death receptor ligation, Bcl-2 family activation, mitochondrial outer membrane permeabilization, cytochrome c release, apoptosome assembly and caspase maturation. These events are opposed by survival kinases such as PI3K, AKT and mTOR, so the net apoptotic output reflects the balance between pro-apoptotic and anti-apoptotic inputs. Experimental studies repeatedly show that shifting this balance toward apoptosis underlies the efficacy of many pharmacological and natural-product interventions. For researchers, GO:2001235 provides a standardized annotation framework for classifying genes, drugs and perturbations that promote cell death. It is used in cancer biology, immunology, hepatology, nephrology and cardiovascular research, where positive regulators of apoptotic signaling are candidate therapeutic targets or biomarkers. This article integrates the QuickGO definition with verified PubMed literature to describe the mechanism, key genes, disease links and CRISPR-based research methods relevant to GO:2001235.
positive regulation of apoptotic signaling pathway At A Glance
| GO ID | GO:2001235 |
|---|---|
| GO term | positive regulation of apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of apoptotic signalling pathway |
| Major function | Activates or increases the frequency, rate or extent of apoptotic signaling pathway |
| Biological context | Cell death decision, tissue homeostasis, stress response, immune surveillance |
| Representative regulators | TP53, BAX, BAK1, BID, caspase-8, caspase-9, caspase-3, FAS, TNFRSF10A/B, APAF1 |
| Opposing pathway | PI3K/AKT/mTOR anti-apoptotic signaling |
| Disease relevance | Cancer, autoimmune disease, acute liver injury, renal tubular injury, myocardial apoptosis |
What Is GO:2001235?
In plain terms, GO:2001235 means any biological process that turns up the volume on apoptotic signaling, making a cell more likely to proceed toward programmed death. The QuickGO definition states that it is any process that activates or increases the frequency, rate or extent of an apoptotic signaling pathway. It is a biological_process term, and its synonym is positive regulation of apoptotic signalling pathway. It does not describe the apoptotic execution machinery itself, but rather the regulatory inputs that amplify or accelerate apoptotic signaling.
Why Is positive regulation of apoptotic signaling pathway Important in Cell Biology?
Positive regulation of apoptotic signaling is important because it determines whether a cell dies in response to damage, infection or developmental cues, and its dysregulation is a direct contributor to human disease. In cancer, tumor cells frequently evade positive apoptotic regulation by upregulating survival pathways such as PI3K/AKT/mTOR, whereas restoring pro-apoptotic signaling can sensitize them to therapy. In inflammatory and metabolic diseases, excessive positive regulation of apoptotic signaling drives tissue injury, as seen in acute liver injury and renal tubular epithelial damage. Understanding GO:2001235 therefore supports target discovery, drug mechanism studies and the design of CRISPR models that test causality of apoptotic regulators.
• Controls the cell death decision and therefore tissue homeostasis and development.
• Mediates immune surveillance by promoting elimination of infected or transformed cells.
• Is frequently suppressed in cancer through PI3K/AKT/mTOR and NF-kB survival signaling.
• Drives pathological tissue injury in acute liver injury and renal tubular epithelial cells.
• Contributes to myocardial cell apoptosis under neurohumoral stimulation.
• Is a mechanistic target of natural compounds such as shikonin, anhydroicaritin and Saccharomyces cerevisiae fractions.
• Provides a framework for annotating pro-apoptotic genes in functional genomics and CRISPR screens.
• Links death receptor signaling, mitochondrial permeabilization and caspase activation into one regulatory node.
• Supports biomarker discovery for therapy response in oncology and inflammation.
• Enables rational design of CRISPR knockout, knock-in and overexpression experiments.
What Happens During positive regulation of apoptotic signaling pathway?
Initiation by death receptor and stress signals
In simple terms: A death signal arrives at the cell surface or inside the cell and starts the apoptotic cascade.
Positive regulation of apoptotic signaling begins when extrinsic ligands such as TRAIL engage death receptors including TNFRSF10A and TNFRSF10B, or when intrinsic stress signals activate the mitochondrial pathway. Death receptor ligation promotes receptor clustering and recruitment of adaptor proteins that initiate caspase activation, while intracellular stress converges on Bcl-2 family regulation. These initiating events are the first committed step that increases apoptotic signaling frequency and rate.
Bcl-2 family activation and mitochondrial outer membrane permeabilization
In simple terms: Pro-death Bcl-2 proteins punch holes in mitochondria, releasing death factors.
Activated BAX and BAK1 oligomerize at the mitochondrial outer membrane to mediate permeabilization, a step amplified by BH3-only proteins such as BID. This permeabilization releases cytochrome c and other intermembrane proteins into the cytosol, converting an upstream signal into an irreversible commitment to apoptosis. Positive regulation at this node is therefore a major determinant of apoptotic sensitivity.
Apoptosome assembly and caspase cascade activation
In simple terms: Released cytochrome c builds a death platform that switches on executioner caspases.
Cytochrome c binds APAF1 to assemble the apoptosome, which recruits and activates caspase-9; caspase-9 then cleaves effector caspases such as caspase-3 and caspase-7. Caspase-8, activated downstream of death receptors, can also cleave BID to engage the mitochondrial amplification loop. This cascade is a central mechanism by which positive regulation of apoptotic signaling is executed and amplified.
Survival signaling that opposes positive regulation
In simple terms: Survival kinases try to block the death signal, and the balance decides the outcome.
PI3K/AKT/mTOR signaling opposes apoptosis by promoting anti-apoptotic Bcl-2 family members and inhibiting pro-apoptotic effectors. In renal tubular epithelial cells, activation of PI3K/Akt/mTOR is associated with an anti-apoptotic effect, whereas inhibition shifts the balance toward apoptosis. Similarly, Akt/NF-kB signaling can suppress apoptosis in colon cancer cells, and its modulation increases apoptotic signaling. Positive regulation of apoptotic signaling therefore reflects the net balance between pro-death and pro-survival inputs.
Pharmacological and natural-product modulation
In simple terms: Drugs and natural compounds can push the balance toward apoptosis.
Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy through modulation of AMPK/mTOR/ULK-1 signaling, illustrating positive regulation of apoptotic signaling by a small molecule. Anhydroicaritin shows selective cytotoxicity in ER-positive breast cancer via ESR1-mediated MAPK and apoptotic signaling. Fufang epimedium formula alleviates acute liver injury through dual modulation of PI3K/AKT/Bcl-2 anti-apoptotic signaling and cGAS-STING-IRF3 anti-inflammatory signaling. These examples show that GO:2001235 is experimentally tractable with pharmacological probes.
Key Genes Involved in GO:2001235 positive regulation of apoptotic signaling pathway
The following genes and proteins are recurrently implicated in positive regulation of apoptotic signaling pathway across the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Transcriptionally activates pro-apoptotic targets such as BAX | Central tumor suppressor in apoptotic signaling research |
| BAX | Forms pores in mitochondrial outer membrane | Key effector of intrinsic apoptosis |
| BAK1 | Oligomerizes with BAX to permeabilize mitochondria | Essential mitochondrial apoptosis regulator |
| BID | Links death receptor signaling to mitochondrial amplification | Crosstalk node between extrinsic and intrinsic pathways |
| CASP8 | Initiator caspase downstream of death receptors | Extrinsic apoptosis initiation |
| CASP9 | Initiator caspase in the apoptosome | Intrinsic apoptosis initiation |
| CASP3 | Executioner caspase | Terminal apoptotic execution |
| CASP7 | Executioner caspase | Terminal apoptotic execution |
| APAF1 | Apoptosome scaffold that activates caspase-9 | Mitochondrial apoptosis platform |
| CYCS | Cytochrome c released from mitochondria | Apoptosome assembly trigger |
| FAS | Death receptor for extrinsic apoptosis | Immune and inflammatory apoptosis |
| TNFRSF10A | TRAIL receptor 1 | Death receptor signaling in cancer |
| TNFRSF10B | TRAIL receptor 2 | Death receptor signaling in cancer |
| PIK3CA | PI3K catalytic subunit promoting survival | Opposes apoptotic signaling |
| AKT1 | Survival kinase inhibiting apoptosis | Anti-apoptotic signaling node |
| MTOR | Survival kinase regulating autophagy and apoptosis | Modulated by shikonin and other compounds |
| BCL2 | Anti-apoptotic guardian protein | Opposes mitochondrial permeabilization |
| ESR1 | Estrogen receptor mediating MAPK/apoptotic signaling | Selective cytotoxicity in breast cancer |
How Is positive regulation of apoptotic signaling pathway Regulated?
Positive regulation of apoptotic signaling is itself regulated by competing survival and stress pathways. PI3K/AKT/mTOR signaling suppresses apoptosis by maintaining anti-apoptotic Bcl-2 family function and limiting pro-apoptotic effector activation. AMPK/mTOR/ULK-1 signaling modulates both apoptosis and autophagy, as shown for shikonin in rheumatoid arthritis. Akt/NF-kB signaling can restrain apoptosis in colon cancer cells, and its inhibition increases apoptotic signaling. Death receptor pathways such as TRAIL signaling are additionally regulated at the level of receptor expression, decoy receptors and downstream caspase activation. Together, these regulatory layers determine whether GO:2001235 is engaged or suppressed.
positive regulation of apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFRSF10A/B | Cancer metastasis and TRAIL sensitivity | Knockout cancer cell lines with TRAIL treatment |
| AKT1 | Colon cancer apoptosis resistance | Point-mutation or knockout colon cancer cells |
| BCL2 | Acute liver injury and apoptosis balance | Overexpression and knockout hepatocyte models |
| MTOR | Renal tubular injury and autophagy-apoptosis crosstalk | Knockout renal tubular epithelial cells |
| ESR1 | ER-positive breast cancer selective cytotoxicity | Knock-in or knockout breast cancer cells |
Cancer and metastasis
Cancer cells commonly evade positive regulation of apoptotic signaling by activating survival pathways and reducing death receptor sensitivity. TRAIL/death receptor signaling is a major target for restoring apoptosis in metastatic cancer, and its regulation directly affects tumor cell survival. Natural compounds such as anhydroicaritin and Saccharomyces cerevisiae fractions promote apoptosis in breast and colon cancer cells through ESR1/MAPK and Akt/NF-kB modulation, respectively.
Inflammatory and autoimmune disease
Positive regulation of apoptotic signaling contributes to the resolution of inflammation and to autoimmune pathology when dysregulated. Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via AMPK/mTOR/ULK-1 signaling, demonstrating that pro-apoptotic modulation can be therapeutic in autoimmune disease. Caspases also regulate inflammatory processes, linking apoptotic signaling to cytokine maturation and inflammatory cell death.
Acute liver injury and renal injury
In acute liver injury, Fufang epimedium formula alleviates damage through dual modulation of PI3K/AKT/Bcl-2 anti-apoptotic signaling and cGAS-STING-IRF3 anti-inflammatory signaling, showing that apoptotic balance is a therapeutic lever. In renal tubular epithelial cells, HeidihuangWan exerts an anti-apoptotic effect via PI3K/Akt/mTOR signaling, indicating that excessive positive regulation of apoptosis contributes to tubular injury.
Cardiovascular apoptosis
Myocardial cell apoptosis is regulated by intracellular signaling pathways downstream of norepinephrine and endothelin-1, which modulate apoptotic signaling in the heart. This places GO:2001235 within the mechanistic framework of stress-induced cardiomyocyte death and heart failure research.
From positive regulation of apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for positive regulation of apoptotic signaling? | CRISPR knockout cell line |
| Does a specific amino acid change alter pro-apoptotic activity? | CRISPR point-mutation knock-in |
| Does tagging a protein affect its apoptotic function? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a pro-apoptotic gene sensitize cells to death? | CRISPR overexpression cell model |
| Which genes modulate apoptotic signaling in a disease context? | CRISPR library screening |
| What pathways are enriched after apoptotic stimulation? | Bioinformatics analysis of transcriptomic data |
How to Study the positive regulation of apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantifying apoptosis after treatment |
| Caspase activity assay | Caspase-3/7/8/9 enzymatic activity | Confirming caspase cascade activation |
| Western blot | Cleaved caspase and Bcl-2 family protein levels | Validating apoptotic signaling |
| RNA sequencing | Transcriptome changes | Pathway enrichment of apoptotic networks |
| CRISPR knockout screen | Gene requirement for apoptosis | Identifying positive regulators |
| CRISPR point-mutation knock-in | Effect of specific variants | Testing causal mutations |
| Overexpression cell model | Gain-of-function apoptotic effect | Testing sufficiency of a gene |
| Bioinformatics analysis | Enriched pathways and networks | Hypothesis generation |
Apoptosis assays
Annexin V staining, caspase activity assays and TUNEL staining quantify apoptotic signaling after genetic or pharmacological perturbation. These assays are used to confirm that a candidate regulator positively or negatively affects apoptosis.
Western blot and signaling analysis
Western blotting of caspase cleavage products, Bcl-2 family proteins and survival kinases such as AKT and mTOR reveals pathway engagement. This method is standard for validating PI3K/AKT/mTOR and MAPK involvement in apoptotic regulation.
Transcriptomic and bioinformatic profiling
RNA sequencing followed by pathway enrichment identifies apoptotic signaling networks altered by a perturbation. Bioinformatics analysis of public datasets can nominate positive regulators of apoptotic signaling for functional testing.
CRISPR functional genomics
CRISPR knockout and library screens systematically test which genes are required for or sufficient to drive apoptotic signaling. These approaches connect genotype to apoptotic phenotype at scale.
How CRISPR Can Be Used to Study GO:2001235 positive regulation of apoptotic signaling pathway
Knockout
CRISPR knockout of candidate genes such as BAX, BAK1, CASP3 or TNFRSF10A/B tests whether they are required for positive regulation of apoptotic signaling. Loss-of-function models are essential for distinguishing causal drivers from correlative markers.
Point Mutation
CRISPR point mutation introduces specific amino acid substitutions to test how individual residues affect pro-apoptotic activity, for example in Bcl-2 family proteins or caspase catalytic sites. This approach links genotype to apoptotic phenotype with precision.
Knock-in
Knock-in of fluorescent or epitope tags allows real-time tracking of apoptotic proteins such as cytochrome c or caspase-3 during cell death. Tagged knock-in models support imaging and proteomic studies of apoptotic signaling dynamics.
Overexpression
CRISPR overexpression of pro-apoptotic genes such as BAX or BID tests whether increased dosage is sufficient to drive apoptotic signaling. Overexpression models are also used to study how survival genes such as AKT1 or BCL2 oppose apoptosis.
How EDITGENE Supports positive regulation of apoptotic signaling pathway Research
Researchers studying positive regulation of apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in promoting or restraining apoptosis, rather than merely correlated with it. This requires precise genetic models that can knock out, mutate, tag or overexpress the gene of interest in relevant cell types. EDITGENE provides these models together with screening and bioinformatics support to accelerate mechanistic discovery in GO:2001235 research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of apoptotic signaling pathway research.
Frequently Asked Questions About positive regulation of apoptotic signaling pathway
What is GO:2001235 positive regulation of apoptotic signaling pathway?
GO:2001235 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of an apoptotic signaling pathway.
What genes are involved in positive regulation of apoptotic signaling pathway?
Key genes include TP53, BAX, BAK1, BID, CASP8, CASP9, CASP3, APAF1, CYCS, FAS, TNFRSF10A, TNFRSF10B, PIK3CA, AKT1, MTOR, BCL2 and ESR1.
How is positive regulation of apoptotic signaling pathway activated?
It is activated by death receptor ligation, Bcl-2 family activation, mitochondrial outer membrane permeabilization, cytochrome c release and caspase cascade activation.
What diseases are linked to positive regulation of apoptotic signaling pathway?
It is linked to cancer, autoimmune disease such as rheumatoid arthritis, acute liver injury, renal tubular injury and myocardial apoptosis.
How do cancer cells evade positive regulation of apoptotic signaling?
Cancer cells often activate PI3K/AKT/mTOR and NF-kB survival signaling and reduce death receptor sensitivity, thereby suppressing apoptosis.
Which natural compounds modulate positive regulation of apoptotic signaling?
Shikonin, Saccharomyces cerevisiae fractions, anhydroicaritin and Fufang epimedium formula have been shown to modulate apoptotic signaling through AMPK/mTOR/ULK-1, Akt/NF-kB, ESR1/MAPK and PI3K/AKT/Bcl-2 pathways.
What is the role of caspases in positive regulation of apoptotic signaling pathway?
Caspases execute and amplify apoptotic signaling, with caspase-8 and caspase-9 as initiators and caspase-3 and caspase-7 as executioners, and they also regulate inflammatory processes.
How can I study positive regulation of apoptotic signaling pathway with CRISPR?
CRISPR knockout, point mutation, knock-in, overexpression and library screening can test whether specific genes are required for or sufficient to drive apoptotic signaling.
What assays measure positive regulation of apoptotic signaling pathway?
Annexin V flow cytometry, caspase activity assays, TUNEL staining, Western blot and RNA sequencing are commonly used to measure apoptotic signaling.
Why is positive regulation of apoptotic signaling pathway important for drug discovery?
Because restoring or inhibiting apoptosis is a therapeutic strategy in cancer, autoimmune disease, liver injury and renal injury, making its regulators candidate drug targets.
Conclusion
GO:2001235, positive regulation of apoptotic signaling pathway, defines the regulatory processes that amplify apoptotic signaling and determine cell fate. Its mechanisms span death receptor signaling, Bcl-2 family control of mitochondrial permeabilization, apoptosome assembly and caspase activation, all balanced against PI3K/AKT/mTOR survival signaling. The term is directly relevant to cancer, autoimmune disease, acute liver injury, renal injury and cardiovascular apoptosis, and it is experimentally accessible through CRISPR knockout, point mutation, knock-in, overexpression and library screening. Researchers can use the genes, models and methods summarized here to design rigorous studies of apoptotic regulation. EDITGENE supports this work with publication-grade CRISPR cell models and bioinformatics services tailored to positive regulation of apoptotic signaling pathway research.
References
- 1. Wang XH et al.. 2024. Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK/mTOR/ULK-1 signaling pathway.. Phytomedicine 128:155512 PMID: 38460357
- 2. Oh YT et al.. 2021. Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.. Biomolecules 11(4) PMID: 33810241
- 3. Shamekhi S et al.. 2020. Apoptotic Effect of Saccharomyces cerevisiae on Human Colon Cancer SW480 Cells by Regulation of Akt/NF-ĸB Signaling Pathway.. Probiotics Antimicrob Proteins 12(1):311-319 PMID: 30788662
- 4. Beltrán-Visiedo M et al.. 2025. Regulation of inflammatory processes by caspases.. Nat Rev Mol Cell Biol 26(11):884-901 PMID: 40603684
- 5. Feng Y et al.. 2025. Fufang epimedium formula alleviates acute liver injury through dual modulation of PI3K/AKT/Bcl-2 anti-apoptotic signaling pathway and cGAS-STING-IRF3 anti-inflammatory signaling pathway.. J Ethnopharmacol 353(Pt B):120415 PMID: 40812556
- 6. Li YY et al.. 2023. Anti-apoptotic effect of HeidihuangWan in renal tubular epithelial cells via PI3K/Akt/mTOR signaling pathway.. J Ethnopharmacol 302(Pt A):115882 PMID: 36341817
- 7. Iwai-Kanai E et al.. 2004. Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis.. Mol Cell Biochem 259(1-2):163-8 PMID: 15124920
- 8. Ying H et al.. 2026. Selective cytotoxicity of anhydroicaritin in ER-positive breast cancer via ESR1-mediated MAPK and apoptotic signaling.. Chem Biol Interact 423:111825 PMID: 41232639
